| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
AD biomarker discovery in CSF and in alternative matrices
|
Sancesario, Giulia
|
|
2019
|
72 |
C |
p. 52-57
|
article
|
| 2 |
Alzheimer's disease: Making the point
|
Bernardini, Sergio
|
|
2019
|
72 |
C |
p. 1-2
|
article
|
| 3 |
Assessment of lipid peroxidation and artificial neural network models in early Alzheimer Disease diagnosis
|
Peña-Bautista, Carmen
|
|
2019
|
72 |
C |
p. 64-70
|
article
|
| 4 |
Blood-based molecular signature of Alzheimer's disease via spectroscopy and metabolomics
|
Habartová, Lucie
|
|
2019
|
72 |
C |
p. 58-63
|
article
|
| 5 |
Clinical aspects of Alzheimer's disease
|
Zvěřová, Martina
|
|
2019
|
72 |
C |
p. 3-6
|
article
|
| 6 |
Differential diagnosis between Alzheimer's disease and other dementias: Role of cerebrospinal fluid biomarkers
|
Farotti, Lucia
|
|
2019
|
72 |
C |
p. 24-29
|
article
|
| 7 |
Editorial Board
|
|
|
2019
|
72 |
C |
p. IFC
|
article
|
| 8 |
Elecsys® Total-Tau and Phospho-Tau (181P) CSF assays: Analytical performance of the novel, fully automated immunoassays for quantification of tau proteins in human cerebrospinal fluid
|
Lifke, Valeria
|
|
2019
|
72 |
C |
p. 30-38
|
article
|
| 9 |
Method comparison study of the Elecsys® β-Amyloid (1–42) CSF assay versus comparator assays and LC-MS/MS
|
Shaw, Leslie M.
|
|
2019
|
72 |
C |
p. 7-14
|
article
|
| 10 |
Neuro-inflammation and anti-inflammatory treatment options for Alzheimer's disease
|
Ozben, Tomris
|
|
2019
|
72 |
C |
p. 87-89
|
article
|
| 11 |
New molecular approaches to Alzheimer's disease
|
Di Resta, Chiara
|
|
2019
|
72 |
C |
p. 81-86
|
article
|
| 12 |
Plasma amyloid beta levels and platelet mitochondrial respiration in patients with Alzheimer's disease
|
Fišar, Zdeněk
|
|
2019
|
72 |
C |
p. 71-80
|
article
|
| 13 |
Search for biomarkers of Alzheimer‘s disease: Recent insights, current challenges and future prospects
|
Hrubešová, Kateřina
|
|
2019
|
72 |
C |
p. 39-51
|
article
|
| 14 |
The standardization of cerebrospinal fluid markers and neuropathological diagnoses brings to light the frequent complexity of concomitant pathology in Alzheimer's disease: The next challenge for biochemical markers?
|
Fenouil, Tanguy
|
|
2019
|
72 |
C |
p. 15-23
|
article
|
Journal description